Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiomyopathy, Hypertrophic | 7 | 2024 | 1265 | 1.480 |
Why?
|
Benzylamines | 5 | 2023 | 223 | 1.380 |
Why?
|
Uracil | 4 | 2023 | 165 | 1.310 |
Why?
|
Influenza Vaccines | 4 | 2023 | 738 | 0.880 |
Why?
|
Heart Failure | 20 | 2024 | 10900 | 0.860 |
Why?
|
Influenza, Human | 6 | 2023 | 1479 | 0.830 |
Why?
|
Ventricular Function, Left | 7 | 2024 | 3670 | 0.710 |
Why?
|
Stroke Volume | 11 | 2024 | 5007 | 0.670 |
Why?
|
Cardiac Myosins | 3 | 2023 | 117 | 0.600 |
Why?
|
Virus Diseases | 1 | 2023 | 711 | 0.590 |
Why?
|
Progeria | 2 | 2024 | 185 | 0.400 |
Why?
|
Heart | 2 | 2023 | 4467 | 0.340 |
Why?
|
Exercise | 4 | 2023 | 5615 | 0.300 |
Why?
|
Atherosclerosis | 3 | 2019 | 3445 | 0.290 |
Why?
|
Cardiovascular Diseases | 5 | 2023 | 15165 | 0.270 |
Why?
|
Motor Activity | 1 | 2015 | 2714 | 0.260 |
Why?
|
Heparin | 2 | 2021 | 1637 | 0.240 |
Why?
|
Atrial Function, Left | 1 | 2023 | 173 | 0.200 |
Why?
|
Echocardiography | 5 | 2021 | 5102 | 0.200 |
Why?
|
Psychomotor Agitation | 1 | 2023 | 293 | 0.190 |
Why?
|
Exercise Tolerance | 2 | 2021 | 770 | 0.180 |
Why?
|
Mortality | 3 | 2021 | 2864 | 0.170 |
Why?
|
Polypharmacy | 1 | 2021 | 294 | 0.170 |
Why?
|
Spironolactone | 1 | 2021 | 382 | 0.160 |
Why?
|
Immunization Schedule | 1 | 2019 | 221 | 0.150 |
Why?
|
Thrombosis | 2 | 2021 | 2968 | 0.150 |
Why?
|
Argentina | 1 | 2017 | 232 | 0.140 |
Why?
|
Hypertension | 2 | 2016 | 8480 | 0.140 |
Why?
|
Aged | 17 | 2023 | 163280 | 0.140 |
Why?
|
Anticoagulants | 2 | 2021 | 4599 | 0.140 |
Why?
|
Death, Sudden | 1 | 2018 | 302 | 0.140 |
Why?
|
Double-Blind Method | 4 | 2021 | 12026 | 0.130 |
Why?
|
Atrial Fibrillation | 2 | 2024 | 5034 | 0.120 |
Why?
|
Leisure Activities | 1 | 2016 | 311 | 0.120 |
Why?
|
Diastole | 1 | 2016 | 791 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 2 | 2019 | 1541 | 0.110 |
Why?
|
Brazil | 1 | 2017 | 1270 | 0.110 |
Why?
|
Hospitalization | 4 | 2021 | 10262 | 0.110 |
Why?
|
Malnutrition | 1 | 2019 | 625 | 0.110 |
Why?
|
Humans | 33 | 2024 | 744343 | 0.110 |
Why?
|
Male | 22 | 2024 | 350118 | 0.100 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2014 | 488 | 0.100 |
Why?
|
Canada | 1 | 2017 | 2065 | 0.100 |
Why?
|
Athletes | 1 | 2018 | 1093 | 0.090 |
Why?
|
Cardiomyopathies | 1 | 2022 | 1912 | 0.090 |
Why?
|
Middle Aged | 16 | 2024 | 213383 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2021 | 1796 | 0.090 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2015 | 859 | 0.090 |
Why?
|
Female | 22 | 2024 | 380194 | 0.090 |
Why?
|
Ventricular Remodeling | 1 | 2016 | 1224 | 0.080 |
Why?
|
Students | 1 | 2018 | 1654 | 0.080 |
Why?
|
Fibrosis | 1 | 2015 | 2029 | 0.080 |
Why?
|
Risk Factors | 10 | 2023 | 72290 | 0.080 |
Why?
|
United States | 6 | 2023 | 69872 | 0.080 |
Why?
|
Heart Arrest | 1 | 2018 | 1470 | 0.080 |
Why?
|
Health Personnel | 1 | 2021 | 3218 | 0.070 |
Why?
|
Heart Defects, Congenital | 1 | 2023 | 4584 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1240 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2017 | 3821 | 0.060 |
Why?
|
Aortic Valve | 1 | 2014 | 1922 | 0.060 |
Why?
|
Prognosis | 3 | 2019 | 29063 | 0.050 |
Why?
|
Mass Screening | 1 | 2018 | 5255 | 0.050 |
Why?
|
Diabetes Mellitus | 2 | 2018 | 5751 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39050 | 0.050 |
Why?
|
Vaccines, Inactivated | 1 | 2021 | 184 | 0.050 |
Why?
|
Incidence | 4 | 2019 | 20947 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12354 | 0.040 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2021 | 339 | 0.040 |
Why?
|
Hemorrhage | 2 | 2021 | 3461 | 0.040 |
Why?
|
Glucosides | 1 | 2022 | 451 | 0.040 |
Why?
|
Wisconsin | 1 | 2018 | 124 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11725 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2019 | 57776 | 0.040 |
Why?
|
Survival Analysis | 2 | 2021 | 10252 | 0.040 |
Why?
|
Hospital Mortality | 2 | 2021 | 5317 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1677 | 0.040 |
Why?
|
Sodium | 1 | 2022 | 1623 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2020 | 690 | 0.040 |
Why?
|
Sex Factors | 2 | 2023 | 10397 | 0.040 |
Why?
|
Denmark | 1 | 2019 | 738 | 0.040 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 845 | 0.030 |
Why?
|
Nutrition Assessment | 1 | 2019 | 723 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2618 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 25043 | 0.030 |
Why?
|
Adult | 7 | 2024 | 214055 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3339 | 0.030 |
Why?
|
Cardiovascular Agents | 1 | 2020 | 850 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2020 | 1869 | 0.030 |
Why?
|
Universities | 1 | 2018 | 956 | 0.030 |
Why?
|
Troponin T | 1 | 2018 | 754 | 0.030 |
Why?
|
Independent Living | 1 | 2016 | 568 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2022 | 2585 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2046 | 0.030 |
Why?
|
Pandemics | 2 | 2022 | 8388 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4397 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2569 | 0.020 |
Why?
|
Hemodynamics | 1 | 2020 | 4199 | 0.020 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2018 | 980 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2018 | 1573 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2050 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3584 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9849 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2021 | 11727 | 0.020 |
Why?
|
Critical Illness | 1 | 2021 | 2670 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6459 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 40075 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 13989 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6538 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9959 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 23338 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2023 | 15076 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7913 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13408 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4468 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 2872 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4034 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5097 | 0.020 |
Why?
|
Comorbidity | 1 | 2018 | 10388 | 0.010 |
Why?
|
Animals | 1 | 2015 | 168757 | 0.010 |
Why?
|
Insulin | 1 | 2018 | 6580 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8089 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12788 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21746 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 5985 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12959 | 0.010 |
Why?
|
Obesity | 1 | 2016 | 12745 | 0.010 |
Why?
|
Adolescent | 1 | 2018 | 85781 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 77449 | 0.010 |
Why?
|
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_